Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM). (Q43266597)
Jump to navigation
Jump to search
scientific article published in October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM). |
scientific article published in October 2009 |
Statements
1 reference
Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM). (English)
1 reference
Carrie Printz
1 reference
1 October 2009
1 reference
1 reference
115
1 reference
20
1 reference
4646
1 reference
Identifiers
1 reference
1 reference